Trial Profile
Treatment of clinically significative diabetic macular edema: influence of bevacizumab, triamcinolone and the combination of both plus macular grid thermal laser photocoagulation of subthreshold
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 04 Jul 2007
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Triamcinolone
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- Acronyms BTP-CSME
- 04 Jul 2007 New trial record.